Seeing Is Believing

Currently out of the existing stock ratings of Ronny Gal, 15 are a HOLD (39.47%), 23 are a BUY (60.53%).
Analyst Ronny Gal, currently employed at BERNSTEIN, carries an average stock price target met ratio of 71.31% that have a potential upside of 22.84% achieved within 344 days.
Ronny Gal’s has documented 78 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABBV, AbbVie at 17-Oct-2024.
Analyst best performing recommendations are on JAZZ (JAZZ PHARMACEUTICALS PLC).
The best stock recommendation documented was for JAZZ (JAZZ PHARMACEUTICALS PLC) at 10/14/2019. The price target of $150 was fulfilled within 44 days with a profit of $32.35 (27.5%) receiving and performance score of 6.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-Feb-2025
$222
$22.85 (11.47%)
$224
4 days ago
(08-Jul-2026)
38/66 (57.58%)
$21.64 (10.80%)
321
Buy Since 04-Mar-2022
$242
$42.85 (21.52%)
$227
5 days ago
(07-Jul-2026)
48/83 (57.83%)
$36.3 (17.65%)
148
Buy Since 29-Jun-2026
$256
$56.85 (28.55%)
$255
13 days ago
(29-Jun-2026)
7/37 (18.92%)
$39.37 (18.17%)
256
Buy Since 28-Sep-2022
$221
$4.97 (2.30%)
$177
27 days ago
(15-Jun-2026)
24/40 (60%)
$22.36 (11.26%)
155
Buy Since 15-May-2026
$225
$8.97 (4.15%)
$214
1 months 27 days ago
(15-May-2026)
4/8 (50%)
$32.05 (16.61%)
54
What Year was the first public recommendation made by Ronny Gal?